Literature DB >> 27888217

A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level.

Siang-Boon Koh1, Patrice Mascalchi2,3, Esther Rodriguez2, Yao Lin2,4, Duncan I Jodrell2, Frances M Richards1, Scott K Lyons2,5.   

Abstract

The fluorescence ubiquitination-based cell cycle indicator (FUCCI) is a powerful tool for use in live cells but current FUCCI-based assays have limited throughput in terms of image processing and quantification. Here, we developed a lentiviral system that rapidly introduced FUCCI transgenes into cells by using an all-in-one expression cassette, FastFUCCI. The approach alleviated the need for sequential transduction and characterisation, improving labelling efficiency. We coupled the system to an automated imaging workflow capable of handling large datasets. The integrated assay enabled analyses of single-cell readouts at high spatiotemporal resolution. With the assay, we captured in detail the cell cycle alterations induced by antimitotic agents. We found that treated cells accumulated at G2 or M phase but eventually advanced through mitosis into the next interphase, where the majority of cell death occurred, irrespective of the preceding mitotic phenotype. Some cells appeared viable after mitotic slippage, and a fraction of them subsequently re-entered S phase. Accordingly, we found evidence that targeting the DNA replication origin activity sensitised cells to paclitaxel. In summary, we demonstrate the utility of the FastFUCCI assay for quantifying spatiotemporal dynamics and identify its potential in preclinical drug development.
© 2017. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Automated microscopy; DNA replication origin; Drug synergy; FUCCI; Live-cell imaging; Taxane

Mesh:

Substances:

Year:  2016        PMID: 27888217     DOI: 10.1242/jcs.195164

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

1.  Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine.

Authors:  Siang-Boon Koh; Yann Wallez; Charles R Dunlop; Sandra Bernaldo de Quirós Fernández; Tashinga E Bapiro; Frances M Richards; Duncan I Jodrell
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

2.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

3.  The nucleus acts as a ruler tailoring cell responses to spatial constraints.

Authors:  A J Lomakin; C J Cattin; D Cuvelier; Z Alraies; M Molina; G P F Nader; N Srivastava; P J Sáez; J M Garcia-Arcos; I Y Zhitnyak; A Bhargava; M K Driscoll; E S Welf; R Fiolka; R J Petrie; N S De Silva; J M González-Granado; N Manel; A M Lennon-Duménil; D J Müller; M Piel
Journal:  Science       Date:  2020-10-16       Impact factor: 47.728

4.  Discovery of a potent cytotoxic agent that promotes G2/M phase cell cycle arrest and apoptosis in a malignant human pharyngeal squamous carcinoma cell line.

Authors:  Manunya Nuth; Manjunatha R Benakanakere; Robert P Ricciardi
Journal:  Int J Oncol       Date:  2022-02-25       Impact factor: 5.650

5.  ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.

Authors:  Tingting Qin; Brendan Mullan; Ramya Ravindran; Dana Messinger; Ruby Siada; Jessica R Cummings; Micah Harris; Ashwath Muruganand; Kalyani Pyaram; Zachary Miklja; Mary Reiber; Taylor Garcia; Dustin Tran; Carla Danussi; Jacqueline Brosnan-Cashman; Drew Pratt; Xinyi Zhao; Alnawaz Rehemtulla; Maureen A Sartor; Sriram Venneti; Alan K Meeker; Jason T Huse; Meredith A Morgan; Pedro R Lowenstein; Maria G Castro; Viveka Nand Yadav; Carl Koschmann
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.995

Review 6.  Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis.

Authors:  Sukanya Basu; Yang Dong; Rahul Kumar; Collene Jeter; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

Review 7.  Recent Advancements in the Regeneration of Auditory Hair Cells and Hearing Restoration.

Authors:  Rahul Mittal; Desiree Nguyen; Amit P Patel; Luca H Debs; Jeenu Mittal; Denise Yan; Adrien A Eshraghi; Thomas R Van De Water; Xue Z Liu
Journal:  Front Mol Neurosci       Date:  2017-07-31       Impact factor: 5.639

8.  Mathematical imaging methods for mitosis analysis in live-cell phase contrast microscopy.

Authors:  Joana Sarah Grah; Jennifer Alison Harrington; Siang Boon Koh; Jeremy Andrew Pike; Alexander Schreiner; Martin Burger; Carola-Bibiane Schönlieb; Stefanie Reichelt
Journal:  Methods       Date:  2017-02-09       Impact factor: 3.608

9.  RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.

Authors:  Siang-Boon Koh; Kenneth Ross; Steven J Isakoff; Nsan Melkonjan; Lei He; Karina J Matissek; Andrew Schultz; Erica L Mayer; Tiffany A Traina; Lisa A Carey; Hope S Rugo; Minetta C Liu; Vered Stearns; Adam Langenbucher; Srinivas Vinod Saladi; Sridhar Ramaswamy; Michael S Lawrence; Leif W Ellisen
Journal:  Clin Cancer Res       Date:  2021-06-24       Impact factor: 12.531

10.  Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.

Authors:  Ethan P Metz; Erin L Wuebben; Phillip J Wilder; Jesse L Cox; Kaustubh Datta; Donald Coulter; Angie Rizzino
Journal:  BMC Cancer       Date:  2020-10-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.